DermTech, Inc. short interest in 2022
In 2022, DermTech, Inc.'s disclosed short interest ran from 17.33% of shares outstanding on 14 Jan 2022 to 8.45% on 30 Dec 2022, a change of -8.88 percentage points. The year's high was 21.82% on 29 Apr 2022 and its low 8.45% on 30 Dec 2022, averaging 13.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.73 days on 28 Feb 2022. Full history: DermTech, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024
2022 in figures
- Start of year
- 17.33% (14 Jan 2022)
- End of year
- 8.45% (30 Dec 2022)
- Change
- -8.88 pp
- High
- 21.82% (29 Apr 2022)
- Low
- 8.45% (30 Dec 2022)
- Average
- 13.94%
- Highest days to cover
- 10.73 (28 Feb 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 17.33% | 6.01 | |
| 31 Jan 2022 | 19.03% | 5.87 | |
| 15 Feb 2022 | 19.79% | 10.21 | |
| 28 Feb 2022 | 19.30% | 10.73 | |
| 15 Mar 2022 | 18.80% | 8.24 | results (8-K), 10-K filed |
| 31 Mar 2022 | 18.63% | 9.00 | |
| 14 Apr 2022 | 19.60% | 10.17 | |
| 29 Apr 2022 | 21.82% | 10.05 | |
| 13 May 2022 | 17.48% | 3.93 | 10-Q filed, results (8-K) |
| 31 May 2022 | 17.28% | 6.73 | |
| 15 Jun 2022 | 17.69% | 5.53 | |
| 30 Jun 2022 | 11.30% | 2.37 | |
| 15 Jul 2022 | 10.38% | 8.00 | |
| 29 Jul 2022 | 13.40% | 3.90 | |
| 15 Aug 2022 | 9.43% | 2.92 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 9.34% | 7.42 | |
| 15 Sep 2022 | 9.61% | 8.01 | |
| 30 Sep 2022 | 9.78% | 6.59 | |
| 14 Oct 2022 | 9.45% | 7.11 | |
| 31 Oct 2022 | 9.17% | 7.45 | |
| 15 Nov 2022 | 9.40% | 2.65 | 10-Q filed |
| 30 Nov 2022 | 9.05% | 5.68 | |
| 15 Dec 2022 | 8.98% | 7.66 | |
| 30 Dec 2022 | 8.45% | 5.54 |
See also: DermTech, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.